Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus
- PMID: 25156735
- PMCID: PMC4249344
- DOI: 10.1128/IAI.01876-14
Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus
Abstract
The localization of Burkholderia cepacia complex (Bcc) bacteria in cystic fibrosis (CF) lungs, alone or during coinfection with Pseudomonas aeruginosa, is poorly understood. We performed immunohistochemistry for Bcc and P. aeruginosa bacteria on 21 coinfected or singly infected CF lungs obtained at transplantation or autopsy. Parallel in vitro experiments examined the growth of two Bcc species, Burkholderia cenocepacia and Burkholderia multivorans, in environments similar to those occupied by P. aeruginosa in the CF lung. Bcc bacteria were predominantly identified in the CF lung as single cells or small clusters within phagocytes and mucus but not as "biofilm-like structures." In contrast, P. aeruginosa was identified in biofilm-like masses, but densities appeared to be reduced during coinfection with Bcc bacteria. Based on chemical analyses of CF and non-CF respiratory secretions, a test medium was defined to study Bcc growth and interactions with P. aeruginosa in an environment mimicking the CF lung. When test medium was supplemented with alternative electron acceptors under anaerobic conditions, B. cenocepacia and B. multivorans used fermentation rather than anaerobic respiration to gain energy, consistent with the identification of fermentation products by high-performance liquid chromatography (HPLC). Both Bcc species also expressed mucinases that produced carbon sources from mucins for growth. In the presence of P. aeruginosa in vitro, both Bcc species grew anaerobically but not aerobically. We propose that Bcc bacteria (i) invade a P. aeruginosa-infected CF lung when the airway lumen is anaerobic, (ii) inhibit P. aeruginosa biofilm-like growth, and (iii) expand the host bacterial niche from mucus to also include macrophages.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Figures










Similar articles
-
Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans.Microbiology (Reading). 2014 Jul;160(Pt 7):1474-1487. doi: 10.1099/mic.0.074203-0. Epub 2014 Apr 30. Microbiology (Reading). 2014. PMID: 24790091
-
Host Adaptation Predisposes Pseudomonas aeruginosa to Type VI Secretion System-Mediated Predation by the Burkholderia cepacia Complex.Cell Host Microbe. 2020 Oct 7;28(4):534-547.e3. doi: 10.1016/j.chom.2020.06.019. Epub 2020 Aug 4. Cell Host Microbe. 2020. PMID: 32755549 Free PMC article.
-
Activation of MMP-9 by human lung epithelial cells in response to the cystic fibrosis-associated pathogen Burkholderia cenocepacia reduced wound healing in vitro.Am J Physiol Lung Cell Mol Physiol. 2011 Oct;301(4):L575-86. doi: 10.1152/ajplung.00226.2010. Epub 2011 Jul 8. Am J Physiol Lung Cell Mol Physiol. 2011. PMID: 21743026
-
Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation.Int J Med Microbiol. 2004 Sep;294(2-3):123-31. doi: 10.1016/j.ijmm.2004.06.022. Int J Med Microbiol. 2004. PMID: 15493822 Review.
-
Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or "Old Hat"?Expert Opin Ther Targets. 2012 Sep;16(9):859-73. doi: 10.1517/14728222.2012.708025. Epub 2012 Jul 16. Expert Opin Ther Targets. 2012. PMID: 22793158 Review.
Cited by
-
Selected strategies to fight pathogenic bacteria.J Enzyme Inhib Med Chem. 2023 Dec;38(1):2155816. doi: 10.1080/14756366.2022.2155816. J Enzyme Inhib Med Chem. 2023. PMID: 36629427 Free PMC article. Review.
-
Physiology and pathophysiology of human airway mucus.Physiol Rev. 2022 Oct 1;102(4):1757-1836. doi: 10.1152/physrev.00004.2021. Epub 2022 Jan 10. Physiol Rev. 2022. PMID: 35001665 Free PMC article. Review.
-
Mutation of hmgA, encoding homogentisate 1,2-dioxygenase, is responsible for pyomelanin production but does not impact the virulence of Burkholderia cenocepacia in a chronic granulomatous disease mouse lung infection.Microbiol Spectr. 2024 Jul 2;12(7):e0041024. doi: 10.1128/spectrum.00410-24. Epub 2024 May 29. Microbiol Spectr. 2024. PMID: 38809005 Free PMC article.
-
Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models.PLoS One. 2017 Mar 1;12(3):e0172723. doi: 10.1371/journal.pone.0172723. eCollection 2017. PLoS One. 2017. PMID: 28248999 Free PMC article.
-
Cystic Fibrosis: Microbiology and Host Response.Pediatr Clin North Am. 2016 Aug;63(4):617-36. doi: 10.1016/j.pcl.2016.04.003. Pediatr Clin North Am. 2016. PMID: 27469179 Free PMC article. Review.
References
-
- Cystic Fibrosis Foundation. 2013. Cystic Fibrosis Foundation patient registry: 2012 annual data report. Cystic Fibrosis Foundation, Bethesda, MD.
-
- Frangolias DD, Mahenthiralingam E, Rae S, Raboud JM, Davidson AGF, Wittmann R, Wilcox PG. 1999. Burkholderia cepacia in cystic fibrosis—variable disease course. Am. J. Respir. Crit. Care Med. 160:1572–1577. - PubMed
-
- Riedel K, Hentzer M, Geisenberger O, Huber B, Steidle A, Wu H, Høiby N, Givskov M, Molin S, Eberl L. 2001. N-Acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology 147:3249–3262. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases